Trial
NCT00603109
Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi Syndrome
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Weill Medical College of Cornell University
Collaborators
National Institutes of Health (NIH); PWSAUSA
Condition
Prader-willi Syndrome
Intervention
rimonabant
Why stopped
Drug side effects leading to premature stop
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-03-20